ici coucou

About us

About us

 

 

“We are a clinical-stage biotech company, focused on Individualized Neoantigen Therapeutic Vaccines (INTV)“

 

Our mission

 

We are a clinical-stage biotech company, focused on Individualized Neoantigen Therapeutic Vaccines (INTV), that emerge as breakthrough immunotherapy for early-stage solid tumor patients.

 

These viral vector-based individualized therapeutic vaccines from Transgene’s myvac® platform aim to unlock the potential of the patient’s immune system to restore the means to fight against the disease. They specifically stimulate and educate the immune system to enable it to recognize and eliminate cancer cells.

#
Lead program:

INTV myvac® platform

employees

“We transform breakthrough science into global solutions dedicated to patients.”